|
|
Volumn 10, Issue 8, 2010, Pages 840-848
|
|
Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MITOGEN ACTIVATED PROTEIN KINASE;
RAF PROTEIN;
RAS PROTEIN;
BRAIN TUMOR;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
GLIOMA;
HUMAN;
METABOLISM;
REVIEW;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
GLIOMA;
HUMANS;
RAF KINASES;
RAS PROTEINS;
MLCS;
MLOWN;
|
|
EID: 79957926581
PISSN: None
EISSN: 18735576
Source Type: Journal
DOI: 10.2174/156800910793357970 Document Type: Review |
|
Times cited : (77)
|
|
References (0)
|
